CD38 and COVID-19: The percentage of CD8+CD38+HLA-DR+ T cell population was significantly higher in the peripheral blood of COVID-19 patients (23.5%), compared to HS (6.5%) and VS (6%) groups (Figure 2C, p<0.001).